Recon Strategy
Contact

Insights

Fifteen+ years of
Healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

Sector
All
NEJM opinion

A golden age for gene therapy: an opinionated take on NEJM highlights for December 2017

  • Biopharma , 
  • NEJM
Successes in gene therapy for hemophilia B and A Hemophilia A and B ar…

Read more